Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
filingDate |
2007-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2009530397-A |
titleOfInvention |
Controlled release formulation of tolterodine |
abstract |
The present invention relates to at least one pharmaceutically acceptable excipient and at least two multiparticulate populations (each population has tolterodine or a salt thereof and the ratio of the population is 90:10 to 10:90), and after 1 month storage at 40 ° C. and 75% relative humidity, the difference between the dissolution profiles at 4 hours is compared to the dissolution profile at the time of manufacture. A stable multiparticulate pharmaceutical composition of tolterodine that is about 5% or less. |
priorityDate |
2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |